Literature DB >> 10670693

Prostaglandins and cyclic nucleotides in the urinary bladder of a rabbit model of partial bladder outlet obstruction.

M A Khan1, C S Thompson, G D Angelini, R J Morgan, D P Mikhailidis, J Y Jeremy.   

Abstract

Bladder outlet obstruction (BOO) is a common disorder that is associated with altered bladder structure and function. For example, it is well established that BOO results in hypertrophy and hyperplasia of the bladder smooth muscle as well as detrusor instability. Since prostaglandins (PGs) and cyclic nucleotides (cyclic AMP [cAMP] and cyclic GMP [cGMP]) mediate both smooth muscle tone and proliferation, it is reasonable to suggest that changes in their levels may be involved in the pathophysiology of BOO-associated bladder disorders. Hence, the objective of this study was to investigate cyclic AMP, cyclic GMP and prostaglandins in the bladder of a rabbit model of BOO. BOO was induced in adult male New Zealand White rabbits. After 3 weeks, urinary bladders were excised, weighed and cut into segments. They were then incubated with stimulators of PGs, cAMP and cGMP and the formation of PGs, cAMP and cGMP were measured using radioimmunoassays. There was a significant increase in the obstructed bladder weights (P=0.002). The formation of PGE2, PGI2, cAMP and cGMP was significantly diminished in the detrusor (P<0.05) and bladder neck (P<0.05) in the BOO bladders compared to age-matched controls. Since PGE2, PGI2, cAMP and cGMP are known to inhibit the proliferation of smooth muscle cells (SMCs), the decreased synthesis of these factors, in BOO, may play a role in bladder SMC hypertrophy/hyperplasia. Our study points to the possible use of drugs that modulate the NO-cGMP and/or PG-cAMP axes in BOO-associated bladder pathology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10670693     DOI: 10.1054/plef.1999.0105

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  7 in total

1.  Prostaglandin E2 induces spontaneous rhythmic activity in mouse urinary bladder independently of efferent nerves.

Authors:  S Kobayter; J S Young; K L Brain
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle.

Authors:  S Oger; D Behr-Roussel; D Gorny; T Lebret; P Validire; X Cathelineau; L Alexandre; F Giuliano
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

3.  Urinary bladder hypertrophy characteristic of male ROMK Bartter's mice does not occur in female mice.

Authors:  Jun-Mo Kim; Shuhua Xu; Xiaoyun Guo; Haiyan Hu; Ke Dong; Tong Wang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-11-01       Impact factor: 3.619

4.  Murine and rat cavernosal responses to endothelin-1 and urotensin-II Vasoactive Peptide Symposium.

Authors:  Fernando S Carneiro; Zidonia N Carneiro; Fernanda R C Giachini; Victor V Lima; Edson Nogueira; William E Rainey; Rita C Tostes; R Clinton Webb
Journal:  J Am Soc Hypertens       Date:  2008-11

5.  DOCA-salt treatment enhances responses to endothelin-1 in murine corpus cavernosum.

Authors:  Fernando S Carneiro; Fernanda R C Giachini; Victor V Lima; Zidonia N Carneiro; Kênia P Nunes; Adviye Ergul; Romulo Leite; Rita C Tostes; R Clinton Webb
Journal:  Can J Physiol Pharmacol       Date:  2008-06       Impact factor: 2.273

Review 6.  Lower urinary tract physiology and pharmacology.

Authors:  M E DiSanto; A J Wein; S Chacko
Journal:  Curr Urol Rep       Date:  2000-10       Impact factor: 2.862

Review 7.  Overactive bladder in the male patient: epidemiology, etiology, evaluation, and treatment.

Authors:  William I Jaffe; Alexis E Te
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.